HTL Hamilton Thorne Ltd

Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024

Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024

BEVERLY, Mass. and TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and six months ended June 30, 2024 before market open on Wednesday, August 14, 2024. The press release, with accompanying financial information, will be posted on the Company’s website at and on .

The Company’s updated investor presentation will be available on Hamilton Thorne’s website shortly after the release. The Company announced it will not be hosting a conference call.

About Hamilton Thorne Ltd. ()

Hamilton Thorne is a leading global provider of precision instruments, laboratory equipment, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, Gynetics, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne Ltd.’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Neither the TSX, nor its regulation services provider (as that term is defined in the policies of the TSX), accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

 
Kate Torchilin, Pres. & CEO

Hamilton Thorne Ltd. 

978-921-2050  



 Francesco Fragasso, CFO

Hamilton Thorne Ltd. 

978-921-2050 

 

 Glen Akselrod

Bristol Investor Relations

905-326-1888

 



EN
07/08/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Hamilton Thorne Ltd

 PRESS RELEASE

Hamilton Thorne Announces Shareholder Approval of Going Private Transa...

Hamilton Thorne Announces Shareholder Approval of Going Private Transaction BEVERLY, Mass. and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ART”), research, and the cell biology fields, today announced that the shareholders of the Company (the "Shareholders"), at a special meeting of Shareholders held earlier today (the "Meeting"), approved a statutory plan of arrangement (the "Transaction") under t...

 PRESS RELEASE

Hamilton Thorne Announces Mailing of Meeting Materials and Receipt of ...

Hamilton Thorne Announces Mailing of Meeting Materials and Receipt of Interim Order in Respect of Going Private Transaction BEVERLY, Mass. and TORONTO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd (TSX: HTL) (“Hamilton Thorne” or the “Company”), a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies (“ART”), research, and the cell biology space, today announced the mailing of its notice of meeting, management information circular (the "Circular"), form of proxy and letter of transmittal (collectively, the "Meetin...

 PRESS RELEASE

Hamilton Thorne Reports Revenue for the Quarter and Six Months Ended J...

Hamilton Thorne Reports Revenue for the Quarter and Six Months Ended June 30, 2024, and Confirms Annual Guidance Revenue of $19.1 million and Adjusted EBITDA of $3.2 million for the quarter BEVERLY, Mass. and TORONTO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported audited financial results for the quarter and six months ended June 30, 2024. Financial Highlights Sal...

 PRESS RELEASE

Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 202...

Hamilton Thorne to Release Q2 2024 Financial Results on August 14, 2024 BEVERLY, Mass. and TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three and six months ended June 30, 2024 before market open on Wednesday, August 14, 2024. The press release, with accompanying financial information, will be posted on the C...

 PRESS RELEASE

Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2...

Hamilton Thorne Announces Agreement to be Acquired by Astorg for CAD$2.25 Per Share in Cash Purchase price of CAD$2.25 per Hamilton Thorne share represents enterprise value of approximately CAD$388 million (US$282 million).Represents a premium of approximately 54% to the closing price on the Toronto Stock Exchange (“TSX”) of Hamilton Thorne shares on July 19, 2024, the last trading day prior to the announcement of the transaction, and approximately 62% to the 90-day VWAP as of the same date1.The Board of Directors of Hamilton Thorne (with interested directors abstaining) unanimously determi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch